Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Driver genes and its clinical significance in non-small cell lung cancer].

Zhongguo fei ai za zhi = Chinese journal of lung cancer - 20 Jun 2014

Shi Yuequan, Yang Xianghong

Abstract excerpt

With the development of molecular biology technology and the transforming patterns of drug research, guiding molecular targeted therapy according to the drive gene mutation spectrum in lung cancer has gradually become a reality. Definition of the mutation incidence and whether existing advantage population groups in non-small cell lung cancer (NSCLC) have important guiding significance in clinical practice. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 24949689
DOI: 10.3779/j.issn.1009-3419.2014.06.08
PMCID: PMC6000100

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Driver genes and its clinical significance in non-small cell lung cancer].PMID 24949689Read ↗

[Advances on driver oncogenes of non-small cell lung cancer].Semantic proximity Read ↗

[Advances on Driver Mutations of Small Cell Lung Cancer].Semantic proximity Read ↗

Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapiesSemantic proximity Read ↗

Prevalence of driver mutations in non-small-cell lung cancers in the People&rsquo;s Republic of ChinaSemantic proximity Read ↗

[Advances on driver oncogenes of lung adenocarcinoma].Semantic proximity Read ↗

NSCLC: An Update of Driver Mutations, Their Role in Pathogenesis and Clinical Significance.Semantic proximity Read ↗

Genomic Profiling of Driver Gene Mutations in Chinese Patients With Non-Small Cell Lung CancerSemantic proximity Read ↗

[Research Advances of Pan-negative Type of Non-small Cell Lung Cancer].Semantic proximity Read ↗

Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacySemantic proximity Read ↗

Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancerSemantic proximity Read ↗

[Driver genes expression and clinical characteristics of targeted therapy in non-small cell lung cancer in Yunnan-Kweichow Plateau].Semantic proximity Read ↗

Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.